tweenvest

Forte Biosciences, Inc. (NasdaqGM: FBRX)

Health Care · Biotechnology · US

$76.99

+0.03% today · +311.5% 1Y

Public summary
A free snapshot of Forte Biosciences, Inc., with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

Forte Biosciences, Inc. (NasdaqGM: FBRX) operates in the Biotechnology industry within the Health Care sector.

Over the last twelve months the share price has gained 311.5%, trading between 15.51 and 77.20.

Tweenvest scores Forte Biosciences, Inc. across four factors: quality 35/100, value 100/100. Its strongest factor is value.

FBRX price history

Nov 21, 2025 · 18.42Weekly closes 16.52 – 76.99Aug 26, 2026 · 76.99

Key figures

Market cap
—
Revenue (TTM)
—
P/E
-22.05
EPS
-4.56
Dividend yield
—
Beta (5Y)
—
52-week high
$77.20
52-week low
$15.51
Avg volume (3M)
—
Shares outstanding
—
Employees
23
Next earnings
—

About Forte Biosciences, Inc.

Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.

ISIN
US34962G2084
Listed since
Apr 13, 2017
Exchange
Nasdaq Global Market
Currency
USD
CompanyMarket capPriceDay
Rebus Holdings, Inc.OTCPK: RBSH$32.00$0.00-99.00%
HAVN Life Sciences Inc.OTCPK: HAVL.F$29.00$0.000.00%
TetraLogic Pharmaceuticals CorporationOTCPK: TLOG$24.00$0.00-99.00%
IMV Inc.OTCPK: IMVI.F$15.00$0.00-99.00%
PhaseRx, Inc.OTCPK: PZRX.Q$12.00$0.000.00%
ContraFect CorporationOTCPK: CFRX.Q$11.00$0.000.00%
Notable Labs, Ltd.OTCPK: NTBL.Q$10.00$0.000.00%
OncoSec Medical IncorporatedOTCPK: ONCS.Q$6.00$0.000.00%

Browse every Biotechnology company →